Rep. Larry Bucshon (R-Ind.) yesterday announced he will retire from Congress at the end of this session. Bucshon, who has [...] …
Year: 2024
A Nebraska state senator has introduced legislation to bar any drugmaker restrictions on arrangements between contract pharmacies and 340B providers. [...] …
SPONSORED CONTENT
In 2024, pharmacy will play an even more significant and critical role in health systems’ financial and operational performance nationwide. While health systems face daunting challenges, increasing risks, and suffocating regulatory and compliance burdens, high-performing pharmacy organizations
…
A Memphis-based health system agreed to a $7.25 million settlement—without admitting wrongdoing—of federal allegations that it paid kickbacks funded, in [...] …
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...] …
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...] …
The Biden administration will not appeal a high-profile November federal court ruling to prohibit enforcement of a 340B patient definition [...] …
Federal auditors determined terminations from the 340B program were required for either covered entity sites or a contract pharmacy of [...] …
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...] …
Among the many tumultuous developments affecting the 340B discount drug program in 2023, the most popular news articles in 340B [...] …